4-[2-(5-Nitroimidazol-1-yl)ethyl]morpholine;4-[2-(5-nitro-1-imidazolyl)ethyl]morpholine;6506-37-2;1-(2-N-Morpholinylethyl)-5-nitroimidazole;1-(N-p-Ethylmorpholine)-5-nitroimidazole;1-(beta-Morpholinoethyl)-5-nitroimidazole;4-(2-(5-Nitroimidazol-1-yl)ethyl)-morpholine;4-(2-(5-Nitroimidazol-1-yl)ethyl)morpholine;Acterol;Acterol forte;BRN 0533758;EINECS 229-394-4;Esclama;K 1900;K-1900;Morpholine, 4-(2-(5-nitro-1H-imidazol-1-yl)ethyl)- (9CI);Morpholine, 4-(2-(5-nitroimidazol-1-yl)ethyl)-;N-2-Morpholinoethyl-5-nitroimidazole;NSC 107524;Naxofem;Naxogin;Nimorazol;Nimorazol [INN-Spanish];Nimorazole;Nimorazole [BAN:INN];Nimorazolo [DCIT];Nimorazolum [INN-Latin];Nitrimidazine;Nulogyl;Sirledi;1-(.beta.-Morpholinoethyl)-5-nitroimidazole;4-[2-(5-Nitroimidazol-1-yl)ethyl]morpholine;Morpholine, 4-[2-(5-nitro-1H-imidazol-1-yl)ethyl]-;Morpholine, 4-[2-(5-nitroimidazol-1-yl)ethyl]-;NSC107524;WLN: T6N DOTJ A2- AT5N CNJ ENW
4-[2-(5-Nitroimidazol-1-yl)ethyl]morpholine